Showing results (271-280 of 326) with videos related to

Sort By:
Pageof 33
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 11, 2026
The impact of progressive expansion of elexacaftor-tezacaftor-ivacaftor availability on lung transplant for cystic fibrosis in FranceThéo Dhôte, Dominique Grenet, Martine Reynaud-Gaubert, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 6, 2022
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosisClémence Martin, Martine Reynaud-Gaubert, Rebecca Hamidfar, et al.
Frontiers in Public Health|December 1, 2022
Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)Nadia Oubaya, Thibaud Pombet, Celine Delestrain, et al.
Clinical Genetics|October 22, 2009
Non-classic cystic fibrosis associated with D1152H CFTR mutationP-R Burgel, I Fajac, D Hubert, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 26, 2009
Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanismsHeidrun Ellinger-Ziegelbauer, Jennifer M Fostel, Chinami Aruga, et al.
Journal of the American College of Cardiology|December 3, 2016
Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in SwineShathiyah Kulandavelu, Vasileios Karantalis, Julia Fritsch, et al.
Scientific Reports|August 9, 2017
Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulatorsIwona M Pranke, Aurélie Hatton, Juliette Simonin, et al.
The Journal of Clinical Investigation|August 9, 2008
The PKC inhibitor AEB071 may be a therapeutic option for psoriasisHans Skvara, Markus Dawid, Elise Kleyn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 5, 2016
Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody CharacteristicsA Roux, I Bendib Le Lan, S Holifanjaniaina, et al.
Annals of the American Thoracic Society|April 5, 2024
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung DiseasePierre-Régis Burgel, Jean-Louis Paillasseur, Isabelle Durieu, et al.
Pageof 33